{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T10:21:30Z","timestamp":1704190890118},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2011,1,25]],"date-time":"2011-01-25T00:00:00Z","timestamp":1295913600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1007\/s12032-011-9821-3","type":"journal-article","created":{"date-parts":[[2011,1,24]],"date-time":"2011-01-24T14:59:27Z","timestamp":1295881167000},"page":"1068-1072","source":"Crossref","is-referenced-by-count":8,"title":["Overexpression of Fc mu receptor (FCMR, TOSO) gene in chronic lymphocytic leukemia patients"],"prefix":"10.1007","volume":"29","author":[{"given":"Veysel Sabri","family":"Hancer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reyhan","family":"Diz-Kucukkaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melih","family":"Aktan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,1,25]]},"reference":[{"key":"9821_CR1","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1200\/JCO.1999.17.1.399","volume":"17","author":"F Caligaris-Cappio","year":"1999","unstructured":"Caligaris-Cappio F, Hamblin TJ. B-cell chronic lymphocytic leukemia: a bird of a differentfeather. J Clin Oncol. 1999;17:399\u2013408.","journal-title":"J Clin Oncol"},{"key":"9821_CR2","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1182\/blood.V94.6.1840","volume":"94","author":"RN Damle","year":"1999","unstructured":"Damle RN, Wasil T, Fais F, Ghiotto F, Valetto A, Allen SL, Buchbinder A, Budman D, Dittmar K, Kolitz J, Lichtman SM, Schulman P, Vinciguerra VP, Rai KR, Ferrarini M, Chiorazzi N. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood. 1999;94:1840\u20137.","journal-title":"Blood"},{"key":"9821_CR3","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0140-6736(03)15260-9","volume":"363","author":"JA Orchard","year":"2004","unstructured":"Orchard JA, Ibbotson RE, Davis Z, Wiestner A, Rosenwald A, Thomas PW, Hamblin TJ, Staudt LM, Oscier DG. ZAP-70 expression and prognosis in chronic lymphocytic leukaemia. Lancet. 2004;363:105\u201311.","journal-title":"Lancet"},{"key":"9821_CR4","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1056\/NEJMoa040857","volume":"351","author":"LZ Rassenti","year":"2004","unstructured":"Rassenti LZ, Huynh L, Toy TL, Chen L, Keating MJ, Gribben JG, Neuberg DS, Flinn IW, Rai KR, Byrd JC, Kay NE, Greaves A, Weiss A, Kipps TJ. ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia. N Engl J Med. 2004;351:893\u2013901.","journal-title":"N Engl J Med"},{"key":"9821_CR5","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1084\/jem.194.11.1625","volume":"194","author":"U Klein","year":"2001","unstructured":"Klein U, Tu Y, Stolovitzky GA, Mattioli M, Cattoretti G, Husson H, Freedman A, Inghirami G, Cro L, Baldini L, Neri A, Califano A, Dalla-Favera R. Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells. J Exp Med. 2001;194:1625\u201338.","journal-title":"J Exp Med"},{"key":"9821_CR6","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1084\/jem.194.11.1639","volume":"194","author":"A Rosenwald","year":"2001","unstructured":"Rosenwald A, Alizadeh AA, Widhopf G, Simon R, Davis RE, Yu X, Yang L, Pickeral OK, Rassenti LZ, Powell J, Botstein D, Byrd JC, Grever MR, Cheson BD, Chiorazzi N, Wilson WH, Kipps TJ, Brown PO, Staudt LM. Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia. J Exp Med. 2001;194:1639\u201347.","journal-title":"J Exp Med"},{"key":"9821_CR7","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1172\/JCI23409","volume":"115","author":"BT Messmer","year":"2005","unstructured":"Messmer BT, Messmer D, Allen SL, Kolitz JE, Kudalkar P, Cesar D, Murphy EJ, Koduru P, Ferrarini M, Zupo S, Cutrona G, Damle RN, Wasil T, Rai KR, Hellerstein MK, Chiorazzi N. In vivo measurements document the dynamic cellular kinetics of chronic lymphocytic leukemia B cells. J Clin Invest. 2005;115:755\u201364.","journal-title":"J Clin Invest"},{"key":"9821_CR8","doi-asserted-by":"crossref","first-page":"13944","DOI":"10.1073\/pnas.0506654102","volume":"102","author":"A Cimmino","year":"2005","unstructured":"Cimmino A, Calin GA, Fabbri M, Iorio MV, Ferracin M, Shimizu M, Wojcik SE, Aqeilan RI, Zupo S, Dono M, Rassenti L, Alder H, Volinia S, Liu CG, Kipps TJ, Negrini M, Croce CM. miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci USA. 2005;102:13944\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"9821_CR9","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.leukres.2005.08.006","volume":"30","author":"P Greaney","year":"2006","unstructured":"Greaney P, Nahimana A, Lagopoulos L, Etter AL, Aubry D, Attinger A, Beltraminelli N, Huni B, Bassi I, Sordat B, Demotz S, Dupuis M, Duchosal MA. Fas agonist induces high levels of apoptosis in haematological malignancies. Leuk Res. 2006;30:415\u201326.","journal-title":"Leuk Res"},{"key":"9821_CR10","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.imlet.2004.09.022","volume":"97","author":"C Romano","year":"2005","unstructured":"Romano C, De Fanis U, Sellitto A. Induction of CD95 upregulation does not render chronic lymphocytic leukemia B-cells susceptible to CD95-mediated apoptosis. Immunol Lett. 2005;97:131\u20139.","journal-title":"Immunol Lett"},{"key":"9821_CR11","doi-asserted-by":"crossref","first-page":"15524","DOI":"10.1073\/pnas.242606799","volume":"99","author":"GA Calin","year":"2002","unstructured":"Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, Noch E, Aldler H, Rattan S, Keating M, Rai K, Rassenti L, Kipps T, Negrini M, Bullrich F, Croce CM. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA. 2002;99:15524\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"9821_CR12","doi-asserted-by":"crossref","first-page":"4213","DOI":"10.1182\/blood-2008-05-157255","volume":"112","author":"CP Pallasch","year":"2008","unstructured":"Pallasch CP, Schulz A, Kutsch N, Schwamb J, Hagist S, Kashkar H, Ultsch A, Wickenhauser C, Hallek M, Wendtner CM. Overexpression of TOSO in CLL is triggered by B-cell receptor signaling and associated with progressive disease. Blood. 2008;112:4213\u20139.","journal-title":"Blood"},{"key":"9821_CR13","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1182\/blood-2007-11-124065","volume":"112","author":"R Proto-Siqueira","year":"2008","unstructured":"Proto-Siqueira R, Panepucci RA, Careta FP, Lee A, Clear A, Morris K, Owen C, Rizzatti EG, Silva WA Jr, Falc\u00e3o RP, Zago MA, Gribben JG. SAGE analysis demonstrates increased expression of TOSO contributing to Fas-mediated resistance in CLL. Blood. 2008;112:394\u20137.","journal-title":"Blood"},{"key":"9821_CR14","doi-asserted-by":"crossref","first-page":"5446","DOI":"10.1182\/blood-2007-06-093906","volume":"111","author":"M Hallek","year":"2008","unstructured":"Hallek M, Cheson BD, Catovsky D, Caligaris-Cappio F, Dighiero G, D\u00f6hner H, Hillmen P, Keating MJ, Montserrat E, Rai KR, Kipps TJ. Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines. Blood. 2008;111:5446\u201356.","journal-title":"Blood"},{"key":"9821_CR15","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1093\/nar\/29.9.e45","volume":"29","author":"MW Pfaffl","year":"2001","unstructured":"Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001;29:2002\u20137.","journal-title":"Nucleic Acids Res"},{"key":"9821_CR16","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S1074-7613(00)80551-8","volume":"8","author":"Y Hitoshi","year":"1998","unstructured":"Hitoshi Y, Lorens J, Kitada SI, Fisher J, LaBarge M, Ring HZ, Francke U, Reed JC, Kinoshita S, Nolan GP. Toso, a cell surface, specific regulator of Fas-induced apoptosis in T cells. Immunity. 1998;8:461\u201371.","journal-title":"Immunity"},{"key":"9821_CR17","doi-asserted-by":"crossref","first-page":"9618","DOI":"10.1074\/jbc.M413609200","volume":"280","author":"Y Song","year":"2005","unstructured":"Song Y, Jacob CO. The mouse cell surface protein TOSO regulates Fas\/Fas ligand-induced apoptosis through its binding to Fas-associated death domain. J Biol Chem. 2005;280:9618\u201326.","journal-title":"J Biol Chem"},{"key":"9821_CR18","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1365-3083.2009.02281.x","volume":"70","author":"GH Richter","year":"2009","unstructured":"Richter GH, Mollweide A, Hanewinkel K, Zobywalski C, Burdach S. CD25 blockade protects T cells from activation induced cell death (AICD) via maintenance of TOSO expression. Scand J Immunol. 2009;70:206\u201315.","journal-title":"Scand J Immunol"},{"key":"9821_CR19","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1084\/jem.20091107","volume":"206","author":"H Kubagawa","year":"2009","unstructured":"Kubagawa H, Oka S, Kubagawa Y, Torii I, Takayama E, Kang DW, Gartland GL, Bertoli LF, Mori H, Takatsu H, Kitamura T, Ohno H, Wang JY. Identity of the elusive IgM Fc receptor [FcmuR] in humans. J Exp Med. 2009;206:2779\u201393.","journal-title":"J Exp Med"},{"key":"9821_CR20","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1093\/intimm\/dxp121","volume":"22","author":"H Shima","year":"2010","unstructured":"Shima H, Takatsu H, Fukuda S, Ohmae M, Hase K, Kubagawa H, Wang JY, Ohno H. Identification of TOSO\/FAIM3 as an Fc receptor for IgM. Int Immunol. 2010;22:149\u201356.","journal-title":"Int Immunol"},{"key":"9821_CR21","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/80886","volume":"1","author":"A Shibuya","year":"2000","unstructured":"Shibuya A, Sakamoto N, Shimizu Y, Shibuya K, Osawa M, Hiroyama T, Eyre HJ, Sutherland GR, Endo Y, Fujita T, Miyabayashi T, Sakano S, Tsuji T, Nakayama E, Phillips JH, Lanier LL, Nakauchi H. Fc alpha\/mu receptor mediates endocytosis of IgM- coated microbes. Nat Immunol. 2000;1:441\u20136.","journal-title":"Nat Immunol"},{"key":"9821_CR22","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.bbrc.2007.05.169","volume":"359","author":"A Sigruener","year":"2007","unstructured":"Sigruener A, Buechler C, Bared SM, Grandl M, Aslanidis C, Ugocsai P, Gehrmann M, Schmitz G. E-LDL upregulates TOSO expression and enhances the survival of human macrophages. Biochem Biophys Res Commun. 2007;359:723\u20138.","journal-title":"Biochem Biophys Res Commun"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-011-9821-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12032-011-9821-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-011-9821-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,15]],"date-time":"2020-06-15T23:51:34Z","timestamp":1592265094000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12032-011-9821-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1,25]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["9821"],"URL":"https:\/\/doi.org\/10.1007\/s12032-011-9821-3","relation":{},"ISSN":["1357-0560","1559-131X"],"issn-type":[{"value":"1357-0560","type":"print"},{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,1,25]]}}}